Arterial Pressure Derived Dynamic Parameters to Detect Preload Responsiveness in Spontaneously Breathing Patients

  • STATUS
    Recruiting
  • participants needed
    30
  • sponsor
    CHU de Reims
Updated on 31 July 2024

Summary

The management of septic shock patients includes the infusion of fluids, however fluids may be deleterious if the patient does not respond by increasing cardiac output. By consequence, it is now recommended to predict the fluid response (fluid or preload responsiveness) before infusing them. In this protocol, the investigators will include critically ill patients spontaneously breathing, for whom the physician in charge has decided to test preload responsiveness. The investigators will collect from the continuous monitoring of arterial pressure of the patient the pulse pressure(PP) which is the difference between systolic arterial pressure and diastolic arterial pressure and the pulse pressure variation (PPV) automatically displayed by the monitor in addition to other clinical (hemodynamic, respiratory) parameters. After one minute of passive leg raising manoeuvre (PLR) the investigators collect the same parameters and the investigators will compare the changes of these parameters in patients who are preload responsive to patients who are not. Preload responsiveness will de defined by echocardiographic parameters before and during PLR. More exactly, a surrogate of cardiac output measured by echocardiography wich is VTI of the sub-aorti flow; an increase of more than 12% defines apreload responsive patient.

Description

*Objectives:

Primary : to assess the diagnostic performance of the decrease in pulse pressure variation (PPV) during a passive leg raising test (PLR) to predict preload responsiveness in spontaneously breathing patients hospitalized in intensive care.

Secondary
  • Evaluate the diagnostic performance of the increase in pulse pressure (PP) during a PLR test to predict preload responsiveness in this same population.
  • Compare before/after PLR measurements other hemodynamic data (blood pressure, cardiac output, heart rate).
  • Experimental scheme: it is a diagnostic and monocentric study.
  • Population / patients:

Inclusion criteria:

  • Patient over 18 years old.
  • Hospitalized in intensive care.
  • For which the clinician in charge of the patient will need to predict the response to fluids and decide on a possible infusion of fluids, because of:
  • Acute circulatory failure with mean arterial pressure < 65mmHg or < 30mmHg of its baseline value for hypertensive patients.
  • And/or other signs of hemodynamic instability (tachycardia, mottling, oliguria, hyperlactatemia).
  • In spontaneous ventilation and without ventilatory assistance.
  • Previously equipped with an arterial catheter.
  • Affiliated to a social security scheme.

Non-inclusion criteria:

  • Patient with arrythmia (PPV is not applicable).
  • Patient with intra-abdominal hypertension (PLR test is not valid).
  • Patient with a contraindication/impossibility to the PLR maneuver (lower limb amputation, respiratory intolerance).
  • Patient with poor echogenicity noted previously.
  • Patient protected by law.
  • Investigation Plan:

Patients meeting the inclusion criteria and not presenting any non-inclusion criteria may be included. The patient will be informed, or his/her relatives if he/she is unable to express their will, of the objectives and the progress of the study. If the patient, or his/her relatives, does not object to participate to the study, the course of the study will be as follows:

  1. The following measurements will be performed before and after the PLR test in spontaneously breathing patients (SB) to evaluate the preload dependency:
    • Hemodynamic data: systolic (SAP), diastolic (DAP), mean (MAP), pulse pressure (PP), heart rate (HR), value of the Pulse Pressure Variation (PPV), cardiac index (CI) if cardiac output monitoring is already present.
    • Echographic data including: time-velocity integral of sub-aortic flow VTI Sub AO); aortic outflow chamber diameter (Diam outflow tract); data from the transmitral pulsed Doppler as well as the data from the tissue Doppler at the mitral annulus (E wave velocity; A wave; E' wave); left ventricular end-diastolic surface.
  2. Collection of demographic parameters (age, sex, comorbidities), acute pathology and severity scores (SAPSII, APACHE II, SOFA) in the patient file.
  3. Collection of oxygenation parameters: mode (conventional oxygen therapy or High Flow), Fio2 or liter O2/min, Flow if applicable.

Details
Condition Hypovolemia
Age 18years or above
Treatment Detection of preload responders by a PLR test
Clinical Study IdentifierNCT06480942
SponsorCHU de Reims
Last Modified on31 July 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Patient over 18 years old
Hospitalized in intensive care
For which the clinician in charge of the patient will need to predict the response to fluids and decide on a possible infusion of fluids, because of
Acute circulatory failure with mean arterial pressure < 65mmHg or < 30mmHg of its baseline value for hypertensive patients
And/or other signs of hemodynamic instability (tachycardia, mottling, oliguria, hyperlactatemia)
In spontaneous ventilation and without ventilatory assistance
Previously equipped with an arterial catheter
Affiliated to a social security scheme

Exclusion Criteria

Patient with arrythmia (PPV is not applicable)
Patient with intra-abdominal hypertension (PLR test is not valid)
Patient with a contraindication/impossibility to the PLR maneuver (lower limb amputation, respiratory intolerance)
Patient with poor echogenicity noted previously
Patient protected by law
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.